Both in Pharmaceuticals
Sarepta Therapeutics, vs Agios Pharmaceuticals
Over the past year SRPT returned −22.0% and AGIO returned −21.8%; their daily moves had a correlation of 0.24.
SRPT −22.0% AGIO −21.8%Growth of $1, one year, split-adjusted
| Metric | SRPT | AGIO |
|---|---|---|
| Price | $19.06 | $31.38 |
| Market cap | $2.01B | $1.87B |
| Today | +2.80% | +0.58% |
| 1 month | +10.1% | −1.1% |
| 6 months | −17.2% | +16.3% |
| Year to date | −11.4% | +15.3% |
| 1 year | −22.0% | −21.8% |
| Revenue growth (YoY) | −34.3% | +259.3% |
| Gross margin | 62.8% | 93.3% |
| Net margin | −1.2% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 19.1× |
| Net cash | -$59.1M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 58.0% |
| Short % of float | 22.7% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).